Cosette M Wheeler

Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA

Frank Struyf, Brigitte Colau, Cosette M Wheeler, 2014, Clinical and Vaccine Immunology.

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.

Alina Deshpande, John P Nolan, Cosette M Wheeler, 2005, The Journal of infectious diseases.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Daron G Ferris, Cosette M Wheeler, Diane M Harper, 2007, The New England journal of medicine.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Joakim Dillner, Daron G Ferris, Susanne K Kjaer, 2010, Journal of the National Cancer Institute.

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States

Jack Cuzick, Cosette M Wheeler, Philip E Castle, 2014, International journal of cancer.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Cosette M Wheeler, Diane M Harper, Mark H Stoler, 2005, The Lancet. Oncology.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Henry C Kitchener, Bart Spiessens, Frank Struyf, 2007, The Lancet.